Pluri Secures $6.5 Million Investment and Acquires Majority Stake in Cell-Based Cacao Producer Kokomodo
Biotechnology firm Pluri Inc., a company specializing in cell-based technology, has announced a $6.5 million private investment led by global investor Alejandro Weinstein. As part of the transaction, Weinstein will join Pluri’s Board of Directors. Concurrently, the company is acquiring a 71% stake in Israeli AgTech firm Kokomodo Ltd., which focuses on cultivated cacao production, for $4.5 million in common shares. The proceeds from the investment will be used to …
Pluri Receives First-Ever Patent for 3D Bioreactor Technology in Plant Cell Cultivation
Pluri (Nasdaq:PLUR) (TASE:PLUR), parent company of the recently launched cell-based coffee biotech PluriAgtech, announces that it has secured a patent from the Israel Patent Office for its “System for 3D Cultivation of Plant Cells and Methods of Use.” Pluri claims this is the first-ever patent approval for 3D bioreactor technology in plant cell cultivation. Pluri’s 3D technology enables the cultivation of plant cells in bioreactors to develop sustainable and disease-free plant …
PluriAgtech Introduces Cell-Based Coffee to Provide an Alternative to Traditional Production
Israeli biotechnology firm Pluri, formerly Pluristem, (Nasdaq, TASE: PLUR) has launched PluriAgtech, a subsidiary leveraging plant cell culture to grow sustainable coffee and break away from traditional farming methods. As global warming continues to impact the coffee industry, shrinking viable land for cultivation and increasing demand leads to higher prices and less production. According to the company, by 2050, land for coffee production will be reduced by half, and 30% …